Management ChangeMay 29, 2026, 05:12 PM
Cencora Appoints Eva Boratto as CFO; Reaffirms FY26 Guidance
AI Summary
Cencora, Inc. announced the appointment of Eva C. Boratto as Executive Vice President and Chief Financial Officer, effective June 29, 2026. Ms. Boratto, with extensive experience from Bath & Body Works, Opentrons Labwork, CVS Health, and Merck, succeeds James F. Cleary, who is retiring and will transition to an advisory role. Her compensation package includes a $1,000,000 annual base salary, a 100% bonus target, a $2,000,000 sign-on bonus, and a $6,000,000 restricted stock unit award. Additionally, Cencora reaffirmed its fiscal year 2026 adjusted diluted EPS guidance of $17.70 to $17.90 and its long-term growth guidance for adjusted operating income and adjusted diluted EPS.
Key Highlights
- Eva C. Boratto appointed Executive Vice President and Chief Financial Officer, effective June 29, 2026.
- Ms. Boratto succeeds James F. Cleary, who will retire and serve in an advisory capacity through 2026.
- Ms. Boratto's annual base salary is $1,000,000, with an annual bonus target of 100% of base salary.
- She will receive a one-time cash sign-on bonus of $2,000,000, subject to repayment conditions.
- Ms. Boratto will also receive a one-time restricted stock unit award valued at $6,000,000, vesting over three years.
- Cencora reaffirmed its fiscal year 2026 adjusted diluted EPS guidance range of $17.70 to $17.90.
- The company reaffirmed long-term guidance for adjusted operating income growth of 7% to 10%.
- Cencora also reaffirmed long-term adjusted diluted EPS growth guidance of 10% to 14%.
Price Impact
More from COR